Metraipolis › archive › dc_361af8539b45
Modulating CD38 enzymatic activity during antibody-based immunotherapy in multiple myeloma: a basic science perspective — Europe PMC PMID:42136641
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/42136641
- DOI
- 10.3389/fimmu.2026.1769281
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-02T23:06:35.991Z
- SHA-256 of the archived text
840bfe89624427f6b0d14c7fec95f4453452c00d8f77898eee2f16430df56907- Stable URL of this page
https://metraipolis.com/documento/dc_361af8539b45
How to cite
Modulating CD38 enzymatic activity during antibody-based immunotherapy in multiple myeloma: a basic science perspective — Europe PMC PMID:42136641 — Europe PMC (en), https://europepmc.org/article/MED/42136641 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_361af8539b45 (Metraipolis archive dc_361af8539b45, sha256 840bfe89624427f6b0d14c7fec95f4453452c00d8f77898eee2f16430df56907)
BibTeX
@misc{dc361af8539b45,
title = {Modulating CD38 enzymatic activity during antibody-based immunotherapy in multiple myeloma: a basic science perspective — Europe PMC PMID:42136641},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/42136641},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_361af8539b45; sha256 840bfe89624427f6b0d14c7fec95f4453452c00d8f77898eee2f16430df56907},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42136641. Agents can read the archived copy with the MCP tool read_document.